| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63c244464bcf8b51f4c7c5e00520f4cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04481c68d907208b086a245a70cf0708 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate |
2000-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e330e4a3874ccef9defdab83cdf65836 |
| publicationDate |
2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0141754-A3 |
| titleOfInvention |
Inhibitors of collagen-induced platelet aggregation |
| abstract |
The present invention describes a therapeutic method useful for treating or preventing a condition of platelet aggregation, in a subject including administering a pharmaceutically effective amount of a compound or composition that inhibits BTK and collagen induced platelet aggregation. The condition of platelet aggregation includes cardiovascular, hematopoietic and cerbrovascular diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8188034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7691839-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9133198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9181257-B2 |
| priorityDate |
1999-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |